The C. elegans
p53 homolog, CEP-1, has elevated expression in two regions of the germ line: distally within the germline stem cells and at the more proximal region of pachytene exit (Schumacher et al., 2005). Similar to
p53 activity in mammalian systems, CEP-1 causes a cell cycle arrest in the stem cells and apoptosis of differentiated meiotic cells in response to DNA damage (Derry et al., 2001; Schumacher et al., 2001, Derry et al., 2007). However, the canonical inhibitor of
p53, MDM2, is not conserved in C. elegans, suggesting that an alternative mechanism exists for CEP-1 regulation in the absence of genomic stress. We have identified vaccinia-related kinase-1 (
vrk-1) as an inhibitor of CEP-1. VRK-1 is a conserved kinase with enriched expression in proliferating germ lines. Human VRK1 phosphorylates murine
p53 in vitro (Lopez-Borges and Lazo, 2000) and preliminary data indicate that C. elegans VRK-1 phosphorylates CEP-1.
vrk-1(
ok1181) mutant germ lines are very small and have condensed chromosomal morphology. The germline proliferation and chromosomal abnormalities are largely rescued in a
cep-1(
gk138) background, suggesting that
vrk-1 negatively regulates
cep-1. The loss of DNA-checkpoint response effectors
mrt-2,
clk-2, and
hus-1 in the
vrk-1(
ok1181) background failed to rescue germline development, indicating that
vrk-1 regulates
cep-1 either downstream of or parallel to the DNA-damage checkpoint response. Since a
ced-4(
n1162) background failed to rescue either the
vrk-1(
ok1181) or
cep-1(
gk138);
vrk-1(
ok1181) phenotypes, we believe
vrk-1 causes a
cep-1-dependent cell cycle arrest rather than ectopic apoptosis. Given that germline genomic stability is maintained by a rapid response to DNA damage achieved by elevated CEP-1 levels within germline stem cells, CEP-1 must be strictly regulated. We propose that VRK-1 phosphorylation of CEP-1 inhibits the DNA-damage-response pathway that causes cell cycle arrest while sustaining the germ lines ability to respond to genomic stress. The role of VRK-1 in regulating proliferation explains the paradox of elevated CEP-1 levels in the mitotic stem cells despite the lack of MDM2.